Synthetic resins or natural rubbers -- part of the class 520 ser – Synthetic resins – From carboxylic acid or derivative thereof
Reexamination Certificate
2001-09-05
2002-12-24
Woodward, Ana (Department: 1711)
Synthetic resins or natural rubbers -- part of the class 520 ser
Synthetic resins
From carboxylic acid or derivative thereof
C528S354000, C528S357000, C528S361000, C525S437000, C525S411000, C606S077000, C606S230000
Reexamination Certificate
active
06498229
ABSTRACT:
BACKGROUND OF THE INVENTION
Strategies for the synthesis of crystalline absorbable glycolide-based polymers based primarily on glycolide for the production of medical devices that exhibit in-use dimensional stability have been limited to (1) random copolymers with at least 80 percent of their chains derived from glycolide; or (2) segmented/block copolymers which are made by two-step synthesis entailing the preparation of a prepolymer containing a minor Traction of glycolate sequence, following end-grafting with glycolide or a mixture of monomers containing more than 80 percent glycolide. Composition limitations associated with the random copolymer approach and process complexity and fair-to-inadequate reproducibility encountered in the two-step synthesis of segmented glycolide copolymer provided the incentive to explore a simple, and yet reliable, approach to prepare crystalline glycolide copolymer with a broad range of physicochemical properties and possibly unique functional performance.
SUMMARY OF THE INVENTION
Accordingly, this invention deals with the direct, one-step copolymerization of glycolide with one or more cyclic monomers, such as lactide, 1,5-dioxepan-2-one, and preferably, trimethylene carbonate and/or caprolactone using low molecular weight monofunctional or difunctional alcohols, amines, or aminoalcohols as ring opening initiators to produce crystalline copolymers having less than 80 percent glycolide-based sequences in their chains. This invention also deals with the direct copolymerization of glycolide with trimethylene carbonate and/or caprolactone using high molecular weight mono- or di-functional polyalkylene oxide, wherein the initiating functionality is a hydroxylic and/or amino group, to produce crystalline polyether-ester block copolymers with a crystalline copolyester component comprising less than 80 percent glycolide-based sequences.
More specifically, the present invention is directed to a direct method for preparing a crystalline, segmented/block glycolide-based copolymer which involves the single step of heating a mixture of glycolide, a hydroxylic or amine initiator, an organo-metallic catalyst, and at least one further comonomer which is lactide, 1,5-dioxepan-2-one, trimethylene carbonate, caprolactone, or mixtures thereof, to a temperature in the range of from about 110° C. to about 180° C. Preferably, the molar ratio of glycolide to the at least one further comonomer is 80:20 or less. It is also preferred that the molar ratio of glycolide and the at least one further comonomer to catalyst is in the range of about 20,000:1 to about 90,000:1. Preferred initiators include 1,3-propanediol, trimethylol propane, and triethanolamine. In another embodiment, a preferred initiator is a difunctional polyalkylene oxide, preferably polyethylene glycol. For that embodiment it is preferred that the molar ratio of glycolide and the at least one further comonomer to the polyethylene glycol is in the range of from about 10:1 to about 1,000:1.
The present invention is also directed to a crystalline, segmented/block glycolide copolymer having less than about 80% by mole glycolide made by a direct method which involves the single step of heating a mixture of glycolide, an initiator, a catalyst, and at least one further comonomer which is lactide, 1,5-dioxepan-2-one, trimethylene carbonate, caprolactone, or mixtures thereof, to a temperature in the range of from about 110° C. to about 180° C. Preferably the at least one further comonomer is trimethylene carbonate, caprolactone, or mixtures thereof. A preferred end use for the crystalline, segmented/block glycolide copolymer of the present invention is as a molded or extruded medical device.
An alternative embodiment is directed to a crystalline, segmented/block copolymer which has a central block derived from a polyalkylene oxide, and end blocks which have less than about 80% by mole glycolide and at least about 20% by mole of a cyclic monomer which is lactide, 1,5-dioxepan-2-one, trimethylene carbonate, caprolactone, or mixtures thereof, made by a direct method which involves the single step of heating a mixture of glycolide, a functional polyalkylene oxide initiator, a catalyst, and at least one further comonomer which is lactide, 1,5-dioxepan-2-one, trimethylene carbonate, caprolactone, or mixtures thereof, to a temperature in the range of from about 110° C. to about 180° C. Preferably, the central block derived from a polyalkylene oxide comprises polyethylene glycol. Most preferably the polyethylene glycol block has a molecular weight of at least about 5,000 Dalton. One preferred end use for the crystalline copolymer of this embodiment of the present invention is as a hydrophilic medical device having finite solubility in water. Another preferred end use for the crystalline copolymer of this embodiment of the present invention is as a part of a controlled release system for bioactive agents. Yet another preferred end use for the crystalline copolymer of this embodiment of the present invention is as a molded or extruded medical device.
DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS
This invention deals with the direct, one-step copolymerization of a monomer mixture containing less than 80 percent glycolide and the balance being one or more cyclic monomer such as lactide, 1,5-dioxepan-2-one, and preferably, trimethylene carbonate (TMC) and/or caprolactone (CL) using a mono- or di-functional diol, amine, or aminoalcohol, an organometallic catalyst, and the appropriate reaction temperature/time scheme to yield crystalline copolymers. In a preferred embodiment of this invention, a monomer mixture containing less than 80 percent glycolide and more than 20 percent TMC and/or CL is copolymerized in the presence of 1,3-propanediol, or trimethylol propane, or triethanolamine at a monomer to initiator ratio of 300 to 1500 and catalytic amounts of stannous octanoate at a monomer to catalyst ratio of 20,000 to 90,000. One aspect of this invention deals with the direct, one-step synthesis of crystalline, segmented copolymer containing less than 80 percent glycolide-based chain sequences that melt between 150° C. and 220° C. and a crystalline fraction exhibiting a heat of fusion of 20-90 J/g. Another aspect of this invention deals with extrusion of a typical copolymer, having about 70 to 79 percent glycolide-based repeat units, into a monofilament which can be further oriented into suture strands. Another aspect of this invention deals with conversion of a typical copolymer having about 60 and 70 percent of glycolide-based repeat units into molded articles, including connecting tubes or catheters, for use in conjunction with devices applicable in the ophthalmology, orthopedic, cardiovascular, and dialysis areas.
This invention also deals with the direct, one-step copolymerization of a monomer mixture containing less than 80 percent glycolide and the balance being TMC and/or CL using a high molecular weight mono- or di-functional polyalkylene oxide as the ring-opening polymerization initiator, wherein the initiating functionality is a hydroxylic and/or amino group, to produce a crystalline polyether-ester block copolymer with a crystalline copolyester component comprising less than 80 percent glycolide-based sequences. In a preferred embodiment of this invention, a monomer mixture containing less than 80 percent glycolide and more than 20 percent TMC and/or CL is copolymerized in the presence of polyethylene glycol to produce a hydrophilic crystalline copolyether-ester. In a more preferred embodiment a polyethylene glycol, having a molecular weight of more than 5 kDa, is used as the initiator to produce highly hydrophilic copolymer that may have a discernable solubility in water. These copolymers can be used to produce controlled drug delivery systems or can be melt processed by molding or extrusion into absorbable medical devices or a component thereof with unique physicochemical and biological properties. Medical devices based on these polyether-esters can be used in orthopedic, ophthalmic, and cardiovascular devices as w
Gregory Leigh P.
Poly-Med, Inc.
Woodward Ana
LandOfFree
Direct synthesis of segmented glycolide copolymers and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Direct synthesis of segmented glycolide copolymers and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Direct synthesis of segmented glycolide copolymers and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2991722